Anti-Casein Kinase 1 delta/CSNK1D antibody
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Polyclonal Casein Kinase 1 delta/CSNK1D antibody. Suitable for IP, WB and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Synthetic Peptide within Human CSNK1D aa 350-450.
View Alternative Names
HCKID, CSNK1D, Casein kinase I isoform delta, CKI-delta, CKId, Tau-protein kinase CSNK1D
- IP
Supplier Data
Immunoprecipitation - Anti-Casein Kinase 1 delta/CSNK1D antibody (AB264278)
Casein Kinase 1 delta/CSNK1D was immunoprecipitated from 1mg of HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate with ab264278 at 10 μg/mg lysate. Western blot was performed from the immunoprecipitate using ab264278 at 1 μg/ml.
Lane 1 : ab264278 IP in HeLa whole cell lysate.
Lane 2 : Control IgG.
Exposure time : 3 secs.
All lanes:
Immunoprecipitation - Anti-Casein Kinase 1 delta/CSNK1D antibody (ab264278)
Predicted band size: 47 kDa
false
- WB
Supplier Data
Western blot - Anti-Casein Kinase 1 delta/CSNK1D antibody (AB264278)
All lanes:
Western blot - Anti-Casein Kinase 1 delta/CSNK1D antibody (ab264278) at 0.04 µg/mL
Lane 1:
HeLa whole cell lysate at 50 µg
Lane 2:
HeLa whole cell lysate at 15 µg
Lane 3:
HeLa whole cell lysate at 5 µg
Predicted band size: 47 kDa
true
Exposure time: 30s
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Autophagy 18:2615-2635 PubMed35253629
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com